Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Lisata Therapeutics, Inc. (LSTA) Days Sales in Receivables data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.17M |
|
$-16.59M |
|
-- |
|
$0.17M |
|
$18.38M |
|
$-18.21M |
|
$0.66M |
|
$-17.55M |
|
$-17.55M |
|
$-16.59M |
|
$-16.59M |
|
$-16.59M |
|
$-16.59M |
|
$-18.21M |
|
$-18.14M |
|
8.69M |
|
8.69M |
|
$-1.91 |
|
$-1.91 |
|
| Balance Sheet Financials | |
$17.70M |
|
$0.02M |
|
$0.04M |
|
$17.74M |
|
$3.07M |
|
-- |
|
$0.07M |
|
$3.14M |
|
$14.60M |
|
$14.60M |
|
$14.60M |
|
8.83M |
|
| Cash Flow Statement Financials | |
$-15.95M |
|
$15.09M |
|
$0.60M |
|
$16.21M |
|
$15.96M |
|
$-0.25M |
|
$1.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-10711.18% |
|
-10711.18% |
|
-10669.41% |
|
-10322.35% |
|
-9756.47% |
|
$-15.98M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
|
Days Sales in Receivables |
-- |
-113.60% |
|
-113.59% |
|
-93.47% |
|
-113.59% |
|
$1.65 |
|
$-1.84 |
|
$-1.84 |
|